Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.466NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.339NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.229NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.415NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.370NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.421NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.612NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.305NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
unclassifiableNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.10.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.323NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.395NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.153NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.391NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.222NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used